REGENXBIO to Participate in Upcoming Investor Conferences
REGENXBIO (Nasdaq: RGNX) has announced its participation in four major upcoming investor conferences in September 2025. The company will attend the Wells Fargo Healthcare Conference for one-on-one meetings in Boston on September 4, followed by three fireside chat presentations in New York: the Morgan Stanley Global Healthcare Conference on September 8, and both the Baird Global Healthcare Conference and H.C. Wainwright Global Investment Conference on September 9.
Select fireside chat presentations will be available via webcast through REGENXBIO's investor relations website, with recordings accessible for approximately 30 days after each event.
REGENXBIO (Nasdaq: RGNX) ha comunicato la sua partecipazione a quattro importanti conferenze per investitori a settembre 2025. La società sarà al Wells Fargo Healthcare Conference per incontri one-to-one a Boston il 4 settembre, per poi tenere tre interventi in forma di fireside chat a New York: il Morgan Stanley Global Healthcare Conference l'8 settembre e sia il Baird Global Healthcare Conference sia l'H.C. Wainwright Global Investment Conference il 9 settembre.
Alcune fireside chat saranno trasmesse in webcast tramite il sito delle relazioni con gli investitori di REGENXBIO; le registrazioni saranno disponibili per circa 30 giorni dopo ciascun evento.
REGENXBIO (Nasdaq: RGNX) ha anunciado su participación en cuatro importantes conferencias para inversores en septiembre de 2025. La compañía asistirá al Wells Fargo Healthcare Conference para reuniones individuales en Boston el 4 de septiembre, y ofrecerá tres charlas tipo fireside en Nueva York: el Morgan Stanley Global Healthcare Conference el 8 de septiembre, y tanto el Baird Global Healthcare Conference como el H.C. Wainwright Global Investment Conference el 9 de septiembre.
Algunas de las fireside chat estarán disponibles por webcast a través del sitio web de relaciones con inversores de REGENXBIO; las grabaciones podrán consultarse durante aproximadamente 30 días tras cada evento.
REGENXBIO (Nasdaq: RGNX)는 2025년 9월에 열리는 네 건의 주요 투자자 컨퍼런스에 참가한다고 발표했습니다. 회사는 9월 4일 보스턴에서 열리는 Wells Fargo Healthcare Conference에서 일대일 미팅을 진행한 뒤, 뉴욕에서 세 차례의 파이어사이드 채팅을 진행합니다: 9월 8일 Morgan Stanley Global Healthcare Conference, 그리고 9월 9일 Baird Global Healthcare Conference와 H.C. Wainwright Global Investment Conference입니다.
일부 파이어사이드 채팅은 REGENXBIO 투자자 관계 웹사이트를 통해 웹캐스트로 제공되며, 각 행사 후 약 30일 동안 녹화 영상을 시청할 수 있습니다.
REGENXBIO (Nasdaq: RGNX) a annoncé sa participation à quatre grandes conférences investisseurs en septembre 2025. La société assistera au Wells Fargo Healthcare Conference pour des rencontres individuelles à Boston le 4 septembre, puis tiendra trois « fireside chats » à New York : le Morgan Stanley Global Healthcare Conference le 8 septembre, ainsi que le Baird Global Healthcare Conference et le H.C. Wainwright Global Investment Conference le 9 septembre.
Certaines présentations en fireside chat seront diffusées en webcast via le site relations investisseurs de REGENXBIO ; les enregistrements resteront accessibles environ 30 jours après chaque événement.
REGENXBIO (Nasdaq: RGNX) hat seine Teilnahme an vier wichtigen Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen wird am 4. September für Einzelgespräche auf der Wells Fargo Healthcare Conference in Boston vertreten sein und anschließend in New York drei Fireside-Chats halten: am 8. September beim Morgan Stanley Global Healthcare Conference sowie am 9. September beim Baird Global Healthcare Conference und dem H.C. Wainwright Global Investment Conference.
Ausgewählte Fireside-Chats werden per Webcast über die Investor-Relations-Website von REGENXBIO verfügbar sein; Aufzeichnungen sind etwa 30 Tage nach den jeweiligen Veranstaltungen abrufbar.
- None.
- None.
2025 Wells Fargo Healthcare Conference
1x1 Investor Meetings: Thursday, September 4
Location:
Morgan Stanley 23rd Annual Global Healthcare Conference
Fireside Chat: Monday, September 8, 2025 at 11:30 a.m. ET
Location:
Baird 2025 Global Healthcare Conference
Fireside Chat: Tuesday, September 9, 2025 at 8:30 a.m. ET
Location:
H.C. Wainwright 27th Annual Global Investment Conference
Fireside Chat: Tuesday, September 9, 2025 at 2:30 p.m. ET
Location:
Live webcasts of select fireside chats can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.
ABOUT REGENXBIO Inc.
REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; clemidsogene lanparvovec (RGX-121) for the treatment of MPS II and RGX-111 for the treatment of MPS I, both in partnership with Nippon Shinyaku; and surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic retinopathy, in collaboration with AbbVie. Thousands of patients have been treated with REGENXBIO's AAV platform, including those receiving Novartis' ZOLGENSMA®. REGENXBIO's investigational gene therapies have the potential to change the way healthcare is delivered for millions of people. For more information, please visit WWW.REGENXBIO.COM.
Contacts:
Dana Cormack
Corporate Communications
dcormack@regenxbio.com
Investors:
George E. MacDougall
Investor Relations
IR@regenxbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-302540604.html
SOURCE REGENXBIO Inc.
FAQ
When is REGENXBIO (RGNX) presenting at the Morgan Stanley Healthcare Conference 2025?
How can I watch REGENXBIO's (RGNX) investor conference presentations?
Which investor conferences is REGENXBIO (RGNX) attending in September 2025?
Where will REGENXBIO's (RGNX) September 2025 investor conferences take place?
